• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活化的糖皮质激素受体与INHAT组分Set/TAF-Iβ相互作用,并将其从糖皮质激素反应性基因启动子上释放出来,从而解除抑制:这对伴有Set-Can易位的急性未分化白血病中糖皮质激素抵抗的发病机制具有重要意义。

Activated glucocorticoid receptor interacts with the INHAT component Set/TAF-Ibeta and releases it from a glucocorticoid-responsive gene promoter, relieving repression: implications for the pathogenesis of glucocorticoid resistance in acute undifferentiated leukemia with Set-Can translocation.

作者信息

Ichijo Takamasa, Chrousos George P, Kino Tomoshige

机构信息

Section on Pediatric Endocrinology, Reproductive Biology and Medicine Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892-1109, USA.

出版信息

Mol Cell Endocrinol. 2008 Feb 13;283(1-2):19-31. doi: 10.1016/j.mce.2007.10.014. Epub 2007 Nov 17.

DOI:10.1016/j.mce.2007.10.014
PMID:18096310
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2350211/
Abstract

Set/template-activating factor (TAF)-Ibeta, part of the Set-Can oncogene product found in acute undifferentiated leukemia, is a component of the inhibitor of acetyltransferases (INHAT) complex. Set/TAF-Ibeta interacted with the DNA-binding domain of the glucocorticoid receptor (GR) in yeast two-hybrid screening, and repressed GR-induced transcriptional activity of a chromatin-integrated glucocorticoid-responsive and a natural promoter. Set/TAF-Ibeta was co-precipitated with glucocorticoid response elements (GREs) of these promoters in the absence of dexamethasone, while addition of the hormone caused dissociation of Set/TAF-Ibeta from and attraction of the p160-type coactivator GRIP1 to the promoter GREs. Set-Can fusion protein, on the other hand, did not interact with GR, was constitutively co-precipitated with GREs and suppressed GRIP1-induced enhancement of GR transcriptional activity and histone acetylation. Thus, Set/TAF-Ibeta acts as a ligand-activated GR-responsive transcriptional repressor, while Set-Can does not retain physiologic responsiveness to ligand-bound GR, possibly contributing to the poor responsiveness of Set-Can-harboring leukemic cells to glucocorticoids.

摘要

集落刺激因子/模板激活因子(TAF)-Iβ是急性未分化白血病中发现的Set-Can癌基因产物的一部分,是乙酰转移酶抑制剂(INHAT)复合物的一个组成部分。在酵母双杂交筛选中,Set/TAF-Iβ与糖皮质激素受体(GR)的DNA结合结构域相互作用,并抑制GR诱导的染色质整合糖皮质激素反应元件和天然启动子的转录活性。在没有地塞米松的情况下,Set/TAF-Iβ与这些启动子的糖皮质激素反应元件(GREs)共沉淀,而添加激素会导致Set/TAF-Iβ从启动子GREs上解离,并使p160型共激活因子GRIP1与启动子GREs结合。另一方面,Set-Can融合蛋白不与GR相互作用,与GREs组成性共沉淀,并抑制GRIP1诱导的GR转录活性增强和组蛋白乙酰化。因此,Set/TAF-Iβ作为一种配体激活的GR反应性转录抑制因子,而Set-Can对配体结合的GR不保留生理反应性,这可能导致携带Set-Can的白血病细胞对糖皮质激素反应性差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c18/2350211/d46541d91f68/nihms42142f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c18/2350211/10a7403e87e5/nihms42142f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c18/2350211/fa42f5d3a873/nihms42142f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c18/2350211/5ca0651802cf/nihms42142f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c18/2350211/b87cf4120faa/nihms42142f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c18/2350211/e338b9a1c362/nihms42142f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c18/2350211/d46541d91f68/nihms42142f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c18/2350211/10a7403e87e5/nihms42142f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c18/2350211/fa42f5d3a873/nihms42142f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c18/2350211/5ca0651802cf/nihms42142f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c18/2350211/b87cf4120faa/nihms42142f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c18/2350211/e338b9a1c362/nihms42142f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c18/2350211/d46541d91f68/nihms42142f6.jpg

相似文献

1
Activated glucocorticoid receptor interacts with the INHAT component Set/TAF-Ibeta and releases it from a glucocorticoid-responsive gene promoter, relieving repression: implications for the pathogenesis of glucocorticoid resistance in acute undifferentiated leukemia with Set-Can translocation.活化的糖皮质激素受体与INHAT组分Set/TAF-Iβ相互作用,并将其从糖皮质激素反应性基因启动子上释放出来,从而解除抑制:这对伴有Set-Can易位的急性未分化白血病中糖皮质激素抵抗的发病机制具有重要意义。
Mol Cell Endocrinol. 2008 Feb 13;283(1-2):19-31. doi: 10.1016/j.mce.2007.10.014. Epub 2007 Nov 17.
2
Thanatos-associated protein 7 associates with template activating factor-Ibeta and inhibits histone acetylation to repress transcription.与死亡相关的蛋白7与模板激活因子-Iβ结合并抑制组蛋白乙酰化以抑制转录。
Mol Endocrinol. 2006 Feb;20(2):335-47. doi: 10.1210/me.2005-0248. Epub 2005 Sep 29.
3
A signaling role of histone-binding proteins and INHAT subunits pp32 and Set/TAF-Ibeta in integrating chromatin hypoacetylation and transcriptional repression.组蛋白结合蛋白以及INHAT亚基pp32和Set/TAF-Iβ在整合染色质低乙酰化和转录抑制中的信号传导作用。
J Biol Chem. 2004 Jul 16;279(29):30850-5. doi: 10.1074/jbc.M404969200. Epub 2004 May 10.
4
Highly acidic C-terminal domain of pp32 is required for the interaction with histone chaperone, TAF-Ibeta.pp32的高酸性C末端结构域是与组蛋白伴侣TAF-Iβ相互作用所必需的。
Biol Pharm Bull. 2006 Dec;29(12):2395-8. doi: 10.1248/bpb.29.2395.
5
Inhibition of Ku70 acetylation by INHAT subunit SET/TAF-Iβ regulates Ku70-mediated DNA damage response.通过 INHAT 亚基 SET/TAF-Iβ 抑制 Ku70 的乙酰化作用调节 Ku70 介导的 DNA 损伤反应。
Cell Mol Life Sci. 2014 Jul;71(14):2731-45. doi: 10.1007/s00018-013-1525-8. Epub 2013 Dec 5.
6
Modulation of transcription parameters in glucocorticoid receptor-mediated repression.糖皮质激素受体介导的抑制中转录参数的调节
Mol Cell Endocrinol. 2008 Nov 25;295(1-2):59-69. doi: 10.1016/j.mce.2008.05.008. Epub 2008 May 21.
7
H3K27 methylation and H3S28 phosphorylation-dependent transcriptional regulation by INHAT subunit SET/TAF-Iβ.通过 INHAT 亚基 SET/TAF-Iβ 进行的 H3K27 甲基化和 H3S28 磷酸化依赖性转录调控。
FEBS Lett. 2012 Sep 21;586(19):3159-65. doi: 10.1016/j.febslet.2012.06.026. Epub 2012 Jul 13.
8
A novel estrogen receptor alpha-associated protein, template-activating factor Ibeta, inhibits acetylation and transactivation.一种新型雌激素受体α相关蛋白,模板激活因子Iβ,可抑制乙酰化和反式激活。
Mol Endocrinol. 2003 Jan;17(1):67-78. doi: 10.1210/me.2002-0280.
9
Relationship between the structure of SET/TAF-Ibeta/INHAT and its histone chaperone activity.SET/TAF-Iβ/INHAT的结构与其组蛋白伴侣活性之间的关系。
Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4285-90. doi: 10.1073/pnas.0603762104. Epub 2007 Mar 6.
10
Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein.由包含SET癌蛋白的人类细胞复合物INHAT对组蛋白乙酰化和转录的调控。
Cell. 2001 Jan 12;104(1):119-30. doi: 10.1016/s0092-8674(01)00196-9.

引用本文的文献

1
The next decade of SET: from an oncoprotein to beyond.下一个十年的 SET:从癌蛋白到超越。
J Mol Cell Biol. 2024 Jul 1;16(1). doi: 10.1093/jmcb/mjad082.
2
SET-CAN/NUP214 fusion gene in leukemia: general features and clinical advances.白血病中的SET-CAN/NUP214融合基因:一般特征与临床进展
Front Oncol. 2023 Oct 16;13:1269531. doi: 10.3389/fonc.2023.1269531. eCollection 2023.
3
Unusual Presentation of -Associated Concomitant Hematological Neoplasm in a Child-Diagnostic and Treatment Struggle.儿童伴发血液肿瘤的不典型表现——诊断和治疗的困境。
Int J Mol Sci. 2023 Sep 22;24(19):14451. doi: 10.3390/ijms241914451.
4
The SET oncoprotein promotes estrogen-induced transcription by facilitating establishment of active chromatin.SET 癌蛋白通过促进活性染色质的形成促进雌激素诱导的转录。
Proc Natl Acad Sci U S A. 2023 Feb 21;120(8):e2206878120. doi: 10.1073/pnas.2206878120. Epub 2023 Feb 15.
5
Oncoprotein SET dynamically regulates cellular stress response through nucleocytoplasmic transport in breast cancer.癌蛋白 SET 通过核质转运在乳腺癌中动态调节细胞应激反应。
Cell Biol Toxicol. 2023 Aug;39(4):1795-1814. doi: 10.1007/s10565-022-09784-4. Epub 2022 Dec 19.
6
Thirty years of SET/TAF1β/I2PP2A: from the identification of the biological functions to its implications in cancer and Alzheimer's disease.三十年来的 SET/TAF1β/I2PP2A:从鉴定生物功能到其在癌症和阿尔茨海默病中的意义。
Biosci Rep. 2022 Nov 30;42(11). doi: 10.1042/BSR20221280.
7
Determining the Appropriate Treatment for T-Cell Acute Lymphoblastic Leukemia With Fusion: Perspectives From a Case Report and Literature Review.确定伴有融合的T细胞急性淋巴细胞白血病的适当治疗方法:来自一例病例报告及文献综述的观点
Front Oncol. 2021 Mar 26;11:651494. doi: 10.3389/fonc.2021.651494. eCollection 2021.
8
Fusion Gene in Acute Leukemia and Myeloid Neoplasms: Report of Three Cases and a Literature Review.急性白血病和髓系肿瘤中的融合基因:三例报告及文献综述
Onco Targets Ther. 2020 Aug 3;13:7665-7681. doi: 10.2147/OTT.S258365. eCollection 2020.
9
Disclosing the Interactome of Leukemogenic NUP98-HOXA9 and SET-NUP214 Fusion Proteins Using a Proteomic Approach.采用蛋白质组学方法揭示白血病致癌 NUP98-HOXA9 和 SET-NUP214 融合蛋白的相互作用组。
Cells. 2020 Jul 10;9(7):1666. doi: 10.3390/cells9071666.
10
NUP214 in Leukemia: It's More than Transport.NUP214 在白血病中的作用:不止是运输。
Cells. 2019 Jan 21;8(1):76. doi: 10.3390/cells8010076.

本文引用的文献

1
The Smad6-histone deacetylase 3 complex silences the transcriptional activity of the glucocorticoid receptor: potential clinical implications.Smad6-组蛋白去乙酰化酶3复合物使糖皮质激素受体的转录活性沉默:潜在的临床意义。
J Biol Chem. 2005 Dec 23;280(51):42067-77. doi: 10.1074/jbc.M509338200. Epub 2005 Oct 25.
2
Thanatos-associated protein 7 associates with template activating factor-Ibeta and inhibits histone acetylation to repress transcription.与死亡相关的蛋白7与模板激活因子-Iβ结合并抑制组蛋白乙酰化以抑制转录。
Mol Endocrinol. 2006 Feb;20(2):335-47. doi: 10.1210/me.2005-0248. Epub 2005 Sep 29.
3
G protein beta interacts with the glucocorticoid receptor and suppresses its transcriptional activity in the nucleus.G蛋白β亚基与糖皮质激素受体相互作用并抑制其在细胞核中的转录活性。
J Cell Biol. 2005 Jun 20;169(6):885-96. doi: 10.1083/jcb.200409150. Epub 2005 Jun 13.
4
A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity.人类糖皮质激素受体(hGR)配体结合域(LBD)中的一种新型点突变导致全身性糖皮质激素抵抗:hGR LBD C末端在赋予反式激活活性中的重要性。
J Clin Endocrinol Metab. 2005 Jun;90(6):3696-705. doi: 10.1210/jc.2004-1920. Epub 2005 Mar 15.
5
Vpr protein of human immunodeficiency virus type 1 binds to 14-3-3 proteins and facilitates complex formation with Cdc25C: implications for cell cycle arrest.人类免疫缺陷病毒1型的Vpr蛋白与14-3-3蛋白结合,并促进与Cdc25C形成复合物:对细胞周期停滞的影响。
J Virol. 2005 Mar;79(5):2780-7. doi: 10.1128/JVI.79.5.2780-2787.2005.
6
The histone chaperone TAF-I/SET/INHAT is required for transcription in vitro of chromatin templates.组蛋白伴侣TAF-I/SET/INHAT是染色质模板体外转录所必需的。
Mol Cell Biol. 2005 Jan;25(2):797-807. doi: 10.1128/MCB.25.2.797-807.2005.
7
Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance.糖皮质激素诱导的细胞凋亡与糖皮质激素抵抗:分子机制及临床意义
Cell Death Differ. 2004 Jul;11 Suppl 1:S45-55. doi: 10.1038/sj.cdd.4401456.
8
Glucocorticoid and mineralocorticoid receptors and associated diseases.糖皮质激素和盐皮质激素受体及相关疾病。
Essays Biochem. 2004;40:137-55. doi: 10.1042/bse0400137.
9
A signaling role of histone-binding proteins and INHAT subunits pp32 and Set/TAF-Ibeta in integrating chromatin hypoacetylation and transcriptional repression.组蛋白结合蛋白以及INHAT亚基pp32和Set/TAF-Iβ在整合染色质低乙酰化和转录抑制中的信号传导作用。
J Biol Chem. 2004 Jul 16;279(29):30850-5. doi: 10.1074/jbc.M404969200. Epub 2004 May 10.
10
Direct binding of INHAT to H3 tails disrupted by modifications.INHAT与H3尾部的直接结合因修饰而被破坏。
J Biol Chem. 2004 Jun 4;279(23):23859-62. doi: 10.1074/jbc.C400151200. Epub 2004 Apr 19.